Cyclerion Therapeutics, Inc.
CYCN
$2.95
-$0.20-6.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.64M | 3.23M | 2.87M | 4.59M | 5.70M |
| Total Receivables | 581.00K | 556.00K | 44.00K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 256.00K | 421.00K | 621.00K | 116.00K | 308.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 21.00K | 16.00K | 11.00K | 11.00K | 10.00K |
| Total Current Assets | 4.50M | 4.23M | 3.55M | 4.72M | 6.01M |
|
|
|||||
| Total Current Assets | 4.50M | 4.23M | 3.55M | 4.72M | 6.01M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.85M | 9.58M | 8.90M | 10.07M | 11.36M |
|
|
|||||
| Total Accounts Payable | 483.00K | 390.00K | 304.00K | 651.00K | 741.00K |
| Total Accrued Expenses | 539.00K | 272.00K | 353.00K | 427.00K | 539.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 45.00K | 63.00K | 43.00K | 204.00K | 161.00K |
| Total Other Current Liabilities | 45.00K | 63.00K | 43.00K | 204.00K | 161.00K |
| Total Current Liabilities | 1.07M | 725.00K | 700.00K | 1.28M | 1.44M |
|
|
|||||
| Total Current Liabilities | 1.07M | 725.00K | 700.00K | 1.28M | 1.44M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.07M | 725.00K | 700.00K | 1.28M | 1.44M |
|
|
|||||
| Common Stock & APIC | 277.70M | 276.34M | 276.22M | 276.08M | 275.90M |
| Retained Earnings | -268.92M | -267.49M | -268.02M | -267.30M | -265.96M |
| Treasury Stock & Other | -- | -- | -- | -- | -16.00K |
| Total Common Equity | 8.78M | 8.85M | 8.20M | 8.78M | 9.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.78M | 8.85M | 8.20M | 8.78M | 9.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.78M | 8.85M | 8.20M | 8.78M | 9.92M |
|
|
|||||